Omodamola Abisola Aje

Omodamola Aje practices at Berkshire Medical Center in Pittsfield, Massachusetts, part of Berkshire Health Systems.

Omodamola Aje's NPI, 1093207763, was assigned on May 30, 2018. Omodamola Aje holds Massachusetts license 275645.

Omodamola Aje's primary practice is Berkshire Medical Center, at 725 North Street, Pittsfield, MA 01201 in Berkshire County. The practice phone is (413) 447-2000.

Omodamola Aje's primary practice is Berkshire Medical Center in Pittsfield, Massachusetts, part of Berkshire Health Systems. Omodamola Aje is also affiliated with Fairview Hospital. The medical group on file is Fairview Hospital. Dmand AI also links Omodamola Aje to 1 more hospital, 3 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Omodamola Aje practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Omodamola Aje's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Omodamola Aje is licensed in Massachusetts.

CMS data shows 1,098 Medicare services from Omodamola Aje across 5 procedure codes in 2024, for 416 Medicare patients. Medicare paid $59,974 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 416 Medicare patients who saw Omodamola Aje in 2024. The largest group is 65 to 74, with 167 patients. 72% of them have high cholesterol, and 69% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Omodamola Aje's median patient age at 72, with 72% women.

In 2024, Omodamola Aje wrote 1,858 Medicare Part D claims for 356 patients. 32% of them were for generic drugs. CMS names the drug for 1,619 of them, across 34 drugs with 11 or more claims each, at $834,156 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Omodamola Aje accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Omodamola Aje as offering telehealth.

CMS Open Payments shows 4 general payments to Omodamola Aje from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $115.